The Company is continuing to progress its five novel patent-protected pre-clinical anti-cancer medicines through a combination of partnerships with leading academic cancer research centres and at the Company's state of the art laboratory in Stratford-upon-Avon.
The Company has recently carried out pre-clinical development programs with the following leading academic cancer research centres:
Olivia Newton-John Cancer Research Institute, La Trobe University, Melbourne
- Breast cancer metastasis antibody programs
Lowy Cancer Research Centre, University of New South Wales
- Liver and Colorectal cancer Midkine RNA and STAT-6 siRNA programs
Hawkins Laboratory Biochemistry and Genetics, La Trobe University, Melbourne
- Lung cancer metastasis antibody programs
School of Medical Sciences, University of Sydney
- Midkine RNA programs